| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/12/2004 | WO2004066823A2 Methods and compositions for analysis of mitochondrial-related gene expression |
| 08/12/2004 | WO2004057343A3 Detection or determination of variants of factor xiia |
| 08/12/2004 | WO2004057031A3 Methods for identifying therapeutic agents of atherosclerotic plaque lesions |
| 08/12/2004 | WO2004057029A3 Haplotype partitioning |
| 08/12/2004 | WO2004056858A3 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 08/12/2004 | WO2004053157A3 Methods for diagnosing and treating schizophrenia |
| 08/12/2004 | WO2004053144A3 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 08/12/2004 | WO2004050912A3 Method and kit for ribonucleoside-specific detection and quantification |
| 08/12/2004 | WO2004050854A3 Methods for identifying the activity of gene products |
| 08/12/2004 | WO2004048613A3 Dual assay for evaluating activity and cytotoxicity of compounds in the same |
| 08/12/2004 | WO2004048612A3 Bridge-probes for detecting non-contiguous cis-located acd sequences |
| 08/12/2004 | WO2004048551A3 Target for therapy of cognitive impairment |
| 08/12/2004 | WO2004046377A3 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 08/12/2004 | WO2004046305A3 Method and system for cell and/or nucleic acid molecules isolation |
| 08/12/2004 | WO2004045556A3 Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens |
| 08/12/2004 | WO2004045545A3 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 08/12/2004 | WO2004044171A3 Waveguide system for detection of fluorescently labeled nucleic acid sequences |
| 08/12/2004 | WO2004033728A3 Nucleic acid amplification primers for pcr-based clonality studies |
| 08/12/2004 | WO2004033722A3 Genetic profiling and healthcare management: adme (absorption, distribution, metabolism & elimination) & toxicology related genes and probes |
| 08/12/2004 | WO2004032860A3 Hiv vaccine formulations |
| 08/12/2004 | WO2004031374A3 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 08/12/2004 | WO2004029625A3 Detecting molecular binding by monitoring feedback controlled cantilever deflections |
| 08/12/2004 | WO2004027062A3 Functional correction of the -786c/t variance of the human enos gene |
| 08/12/2004 | WO2004025257A3 Methods and systems for estimating the melting temperature (tm) for polynucleotide molecules |
| 08/12/2004 | WO2004025246A3 Multiple gene diagnostic probes and assay kits and method for the assessment of multiple markers for breast cancer prognosis |
| 08/12/2004 | WO2004022785A3 Methods detecting, characterising and monitoring hydrocarbon reservoirs |
| 08/12/2004 | WO2004020976A3 Diagnostic assay for thrombin-activatable fibrinolysis inhibitor (tafi) |
| 08/12/2004 | WO2004020604A3 Allele specific primer extension |
| 08/12/2004 | WO2004016802A3 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 08/12/2004 | WO2004016222A3 Hepatitis c viral-like particle purification |
| 08/12/2004 | WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 08/12/2004 | WO2004011666A3 Mg-mediated hot start biochemical reactions |
| 08/12/2004 | WO2004011594A3 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
| 08/12/2004 | WO2004003512A3 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 08/12/2004 | WO2004003132A3 Methods and systems of biomolecular sequence matching |
| 08/12/2004 | WO2003099998A3 Gene expression profiling of adult soft tissue sarcoma |
| 08/12/2004 | WO2003097869A3 Microsatellite markers for genetic analyses and the differentiation of roses |
| 08/12/2004 | WO2003091406A3 Amplification of dna to produce single-stranded product of defined sequence and length |
| 08/12/2004 | WO2003085372A3 Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003071927A3 Diagnostics and therapeutics for macular degeneration-related disorders |
| 08/12/2004 | WO2003066888A3 Method and apparatus for microorganism identification |
| 08/12/2004 | WO2003066802A3 Gene expression analysis using nicking agents |
| 08/12/2004 | WO2003057825A3 Gene expression patterns in response to atypical and typical neuroleptic agents in the central nervous system |
| 08/12/2004 | WO2003051182A3 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 08/12/2004 | WO2003042693A3 Method for measuring intracellular atp and/or gene expression |
| 08/12/2004 | WO2003039484A3 Novel compositions and methods for cancer |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003026573A3 Screening and selection methods for statin drug combinations |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002086147A3 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 08/12/2004 | US20040158879 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 08/12/2004 | US20040158447 Method for simulating and modeling the presence and growth of microbes, including pathogens and spoilage organisms, through a food supply chain |
| 08/12/2004 | US20040158051 Nucleotide sequence probe comprising quenching agent and zinc sulfide quantum dot for use as nanoparticle tags in biomineralization and crystal growth |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040157917 Central nervous system disorders; psychological disorders |
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157319 contacting molecular recognition headgroups with the analyte; detecting an electrical signal at the electrode substrate resulting from mobile charge carriers generated by redox reaction and transferred by polymer strands to the substrate |
| 08/12/2004 | US20040157313 Ammonia-oxidizing bacteria |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157294 Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157281 by producing visual display response; for enzyme linked immunosorbent assay (ELISA) or other immunoassay; solid phase synthesis |
| 08/12/2004 | US20040157279 Methods of analysis and labeling of protein-protein interactions |
| 08/12/2004 | US20040157272 Cell-based screening methods |
| 08/12/2004 | US20040157269 Function homology screening |
| 08/12/2004 | US20040157263 biosensor for environmental analysis, the food industry, human and veterinary diagnosis, crop protection; solid phase synthesis |
| 08/12/2004 | US20040157262 Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157260 Method for detection of stachybotrys chartarum in pure culture and field samples using quantitative polymerase chain reaction |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157257 Abortive promoter cassettes |
| 08/12/2004 | US20040157255 Gene expression markers for response to EGFR inhibitor drugs |
| 08/12/2004 | US20040157254 Storage unit stores a crosslink map having records according to the version of a genome sequence; information searching and location estimation |
| 08/12/2004 | US20040157253 Methods and compositions for use of inflammatory proteins in the diagnosis and treatment of metabolic disorders |
| 08/12/2004 | US20040157252 Methods for transcription detection and analysis |
| 08/12/2004 | US20040157251 Detecting amount in sample (blood, plasma, or urine) using immunoassay, mass spectrometry or polymerase chain reaction to determine mRNA levels |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157247 Of given formula; used to build up oligomers which can be used for hybridization, probes and detection of nucleic acids; protecting groups, fluorescent dyes, solid phase, phosphoramidite, phosphonate or triphosphate |
| 08/12/2004 | US20040157246 Purified protein encoded by a nucleic acid hybridizable to a DNA of given sequence; use in diagnosis, prognosis and screening for a disposition to cardiovascular disorders |
| 08/12/2004 | US20040157243 Amplifying nucleic acid from sample, hybridizing with probe designed to detect presence different sequences; used to diagnose cancer and diseases associated with chromosomal anomalies |
| 08/12/2004 | US20040157242 Analyzing sample from patient and comparing to reference population both containing measurable amount of a low molecular weight compound (polypeptide); data analysis algorithm; mass spectrometry, liquid chromatography |
| 08/12/2004 | US20040157240 Diagnostic assay and related products |
| 08/12/2004 | US20040157238 At a polymorphic site; contacting labeled amplicons with hybridization probes; comparing wild type and variant complexes; assay kit |
| 08/12/2004 | US20040157237 Optochemical sensing with multi-band fluorescence enhanced by surface plasmon resonance |
| 08/12/2004 | US20040157236 Multitemperature single strand conformation polymorphism (MSSCP) |
| 08/12/2004 | US20040157235 Producing system and its control device, control method, control system, and control program |
| 08/12/2004 | US20040157233 metRS2 |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157230 non-radioactive assay in microtiter plate format enabling colorimetric or fluorimetric product detection for drug screening; solid phase synthesis |
| 08/12/2004 | US20040157229 Methods of profiling gene expression, protein or metabolite levels |
| 08/12/2004 | US20040157228 by measuring zinc regulated nucleic acid molecules expression level indicative of sub-optimal fermentation in a beer brewing |
| 08/12/2004 | US20040157226 for single nucleotide polymorphism (SNP) detection using fluorescence resonance energy transfer; solid phase synthesis; vertical light beam fluorometry |
| 08/12/2004 | US20040157224 no harmful organic solvents are involved, that physical and biochemical degradation/digestion of nucleic acids during the isolation process is minimized |
| 08/12/2004 | US20040157223 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157220 Methods and apparatus for sample tracking |